Simvastatin
Product Images NDC 10544-907

4 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 10544-907). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 mg- 30 Tab (Label Simvastatin Tabs 20mg Bpi(10544 908 90) Accord(16729 005 17) Rev2)

20 mg- 30 Tab (Label Simvastatin Tabs 20mg  Bpi(10544 908 90) Accord(16729 005 17) Rev2)
Simvastatin Tablets, USP 20mg label from Blenheim Pharmacal, Inc. The label indicates a package of 90 tablets, for prescription use only. Storage instructions include keeping at controlled room temperature (20-25°C) and in a light-resistant container out of children's reach. The label also displays NDC and lot number details, along with manufacturer information and barcodes.*
FDA Label Image

80 mg- 30 Tab (Label Simvastatin Tabs 80mg Bpi(10544 907 30) Accord(16729 007 17) Rev2)

80 mg- 30 Tab (Label Simvastatin Tabs 80mg  Bpi(10544 907 30) Accord(16729 007 17) Rev2)
Simvastatin Tablets, USP 80mg label from Blenheim Pharmacal, Inc. The label indicates 30 tablets per package with prescription use only (Rx Only). Storage instructions advise keeping the tablets at 20°-25°C (68°-77°F) in a light-resistant container, out of reach of children. The label includes the NDC 10544-907-30 and manufacturing code 16729-007-17, along with a barcode and multiple repeated listings of the product name and details on the right panel.*
FDA Label Image

Simvastatin (Simvastatin Fig1)

Simvastatin (Simvastatin Fig1)
A forest plot chart presenting the incidence and risk ratio of major vascular events and major coronary events among subgroups of patients treated with simvastatin tablets versus placebo. The chart includes various subgroups based on baseline characteristics such as presence of coronary heart disease (CHD), diabetes status, peripheral and cerebrovascular disease, gender, age, LDL-cholesterol, and HDL-cholesterol levels, showing risk ratios with 95% confidence intervals for each subgroup.*
FDA Label Image

Simvastatin (Simvastatin Str)

Simvastatin (Simvastatin Str)
Chemical structure of simvastatin, showing its molecular configuration with multiple rings, hydroxyl groups, and methyl side chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.